GenrAb | BiotechTV

top of page

A UT Southwestern neurology expert and the CEO of GenrAb discuss neuro-immunology and finding antibodies that can help with neuronal damage

UTSW's Dr. Ben Greenberg discusses how neuro-immunology is making inroads for conditions like MS, ALS, and alzheimer's. GenrAb CEO Larry...

Company News

Oct 30, 2024

Breakfast at biolabs: GenrAb

Larry Tiffany describes how GenrAb is leveraging neurodegenerative stress and immunoogenetic models from UTSW for antibody discovery.

Bright Minds

Oct 26, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

A UT Southwestern neurology expert and the CEO of GenrAb discuss neuro-immunology and finding antibodies that can help with neuronal damage

Breakfast at biolabs: GenrAb

Follow BiotechTV

Sponsors

Sponsor Spotlight